Latest Insider Transactions at Quanterix Corp (QTRX)
This section provides a real-time view of insider transactions for Quanterix Corp (QTRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Quanterix Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Quanterix Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-4.05%
|
$131,693
$79.29 P/Share
|
|
Jan 19
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.16%
|
$375,000
$75.07 P/Share
|
|
Jan 11
2021
|
Marijn E Dekkers |
SELL
Open market or private sale
|
Direct |
44,962
-27.9%
|
$2,203,138
$49.13 P/Share
|
|
Jan 11
2021
|
Marijn E Dekkers |
BUY
Exercise of conversion of derivative security
|
Direct |
44,962
+30.3%
|
$584,506
$13.73 P/Share
|
|
Jan 05
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
98
-0.45%
|
$4,312
$44.13 P/Share
|
|
Jan 05
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
170
-0.55%
|
$7,480
$44.13 P/Share
|
|
Jan 05
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,510
-0.34%
|
$154,440
$44.13 P/Share
|
|
Jan 05
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
153
-0.48%
|
$6,732
$44.13 P/Share
|
|
Jan 05
2021
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
124
-0.48%
|
$5,456
$44.13 P/Share
|
|
Jan 04
2021
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
2,581
+8.63%
|
$56,782
$22.06 P/Share
|
|
Jan 04
2021
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
2,680
+8.37%
|
$58,960
$22.06 P/Share
|
|
Jan 04
2021
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
2,467
+7.55%
|
$54,274
$22.06 P/Share
|
|
Jan 04
2021
|
Marijn E Dekkers |
BUY
Grant, award, or other acquisition
|
Direct |
2,270
+20.0%
|
-
|
|
Jan 04
2021
|
David R Walt |
BUY
Grant, award, or other acquisition
|
Direct |
2,270
+0.18%
|
-
|
|
Jan 04
2021
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
2,539
+9.72%
|
$55,858
$22.06 P/Share
|
|
Dec 18
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.89%
|
$71,681
$43.82 P/Share
|
|
Dec 18
2020
|
David C. Duffy SVP R&D and CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,630
+3.67%
|
$3,260
$2.28 P/Share
|
|
Dec 08
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.2%
|
$92,000
$46.98 P/Share
|
|
Dec 01
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,236
-0.16%
|
$139,148
$43.72 P/Share
|
|
Dec 01
2020
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
141
-0.22%
|
$6,063
$43.72 P/Share
|
|
Dec 01
2020
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
115
-0.22%
|
$4,945
$43.72 P/Share
|
|
Dec 01
2020
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
158
-0.25%
|
$6,794
$43.72 P/Share
|
|
Dec 01
2020
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
91
-0.21%
|
$3,913
$43.72 P/Share
|
|
Nov 24
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
2,070
+35.4%
|
-
|
|
Nov 24
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
454,434
-12.71%
|
-
|
|
Nov 24
2020
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
1,034
+7.96%
|
-
|
|
Nov 24
2020
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
454,434
-12.71%
|
-
|
|
Nov 20
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,707
+50.0%
|
-
|
|
Nov 20
2020
|
Arch Venture Fund Vi LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-9.49%
|
-
|
|
Nov 20
2020
|
Keith Crandell |
BUY
Other acquisition or disposition
|
Direct |
854
+7.25%
|
-
|
|
Nov 20
2020
|
Keith Crandell |
SELL
Other acquisition or disposition
|
Indirect |
375,000
-9.49%
|
-
|
|
Nov 19
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$88,000
$44.25 P/Share
|
|
Nov 16
2020
|
William Geist Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,045
+50.0%
|
-
|
|
Nov 12
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.89%
|
$81,683
$49.39 P/Share
|
|
Nov 12
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$98,000
$49.39 P/Share
|
|
Nov 05
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,372
-10.48%
|
$57,624
$42.45 P/Share
|
|
Nov 05
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,372
+9.49%
|
$2,744
$2.28 P/Share
|
|
Nov 04
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$62,400
$39.4 P/Share
|
|
Nov 04
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Nov 02
2020
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116
-0.46%
|
$4,176
$36.97 P/Share
|
|
Nov 02
2020
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
142
-0.45%
|
$5,112
$36.97 P/Share
|
|
Nov 02
2020
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
159
-0.5%
|
$5,724
$36.97 P/Share
|
|
Nov 02
2020
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
91
-0.43%
|
$3,276
$36.97 P/Share
|
|
Nov 02
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,264
-0.32%
|
$117,504
$36.97 P/Share
|
|
Oct 29
2020
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,000
-0.19%
|
$76,000
$38.3 P/Share
|
|
Oct 20
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$67,200
$42.57 P/Share
|
|
Oct 20
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 19
2020
|
Martin D Madaus |
SELL
Open market or private sale
|
Direct |
1,600
-12.02%
|
$70,400
$44.59 P/Share
|
|
Oct 19
2020
|
Martin D Madaus |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+10.73%
|
$3,200
$2.28 P/Share
|
|
Oct 16
2020
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-3.75%
|
$71,681
$43.04 P/Share
|